Feb 27, 2021
3  Likes 0 Comments
About this Deal
The U.S. Food and Drug Administration has authorized a third COVID-19 vaccine for public use.
As expected on Saturday, acting Commissioner Dr. Janet Woodcock granted an emergency use authorization for a vaccine developed by Janssen Pharmaceuticals, a Johnson & Johnson company.
About 4 million doses of the new vaccine should be made available next week, 20 million total during March, and another 80 million by the end of June. Because the vaccine requires only one dose, it will help protect 100 million people and take effect more rapidly than the two-dose vaccines.